Related Experiment Video
Updated: Mar 8, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Microparticles: Inflammatory and haemostatic biomarkers in Polycystic Ovary Syndrome
L M L Carvalho1, C N Ferreira2, M O Sóter3
1Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Abstract:
Polycystic Ovary Syndrome (PCOS) is associated with a chronic low-grade inflammation and predisposition to hemostatic and atherosclerotic complications. This case-control study evaluated the microparticles (MPs) profile in patients with the PCOS and related these MPs to clinical and biochemical parameters. MPs derived from platelets (PMPs), leuckocytes (LMPs) and endothelial cells (EMPs) were evaluated, as well as MPs expressing tissue factor (TFMPs), by flow cytometry, comparing women with PCOS (n = 50) and a healthy control group (n = 50). PCOS women presented increased total MPs, PMPs, LMPs and EMPs levels when compared to control group (all p < 0.05). TFMPs was similar between the groups (p = 0.379). In conclusion, these MPs populations could be useful biomarkers for association with thrombosis and cardiovascular disease in PCOS women.
Insights
Polycystic Ovary Syndrome (PCOS) is linked to inflammation and cardiovascular risks. Studies show elevated microparticle (MP) levels in PCOS patients, suggesting they could be biomarkers for thrombosis and cardiovascular disease.
Area of Science:
- Endocrinology
- Hematology
- Cardiovascular Research
Background:
- Polycystic Ovary Syndrome (PCOS) is characterized by chronic low-grade inflammation.
- PCOS is associated with an increased risk of hemostatic and atherosclerotic complications.
Purpose of the Study:
- To evaluate the microparticle (MP) profile in women with PCOS.
- To correlate MP levels with clinical and biochemical parameters in PCOS patients.
Main Methods:
- A case-control study comparing 50 women with PCOS and 50 healthy controls.
- Flow cytometry was used to quantify microparticles derived from platelets (PMPs), leukocytes (LMPs), endothelial cells (EMPs), and those expressing tissue factor (TFMPs).
Main Results:
- Women with PCOS exhibited significantly higher levels of total MPs, PMPs, LMPs, and EMPs compared to controls (p < 0.05).
- No significant difference was observed in TFMPs levels between PCOS patients and the control group (p = 0.379).
Conclusions:
- Elevated populations of PMPs, LMPs, and EMPs may serve as useful biomarkers in PCOS.
- These microparticle profiles could indicate an association with thrombosis and cardiovascular disease risk in women with PCOS.
Related Concept Videos
Oogenesis
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

